Ad
CANF - Can Fite Biopharma Ltd Sponsored ADR Stock Trading
About | Can-Fite Biopharma Ltd Sponsored ADR (NYSE:CANF)
None
Quote | Can-Fite Biopharma Ltd Sponsored ADR (NYSE:CANF)
| Last: | $2.32 |
|---|---|
| Change Percent: | 0.0% |
| Open: | $2.44 |
| Close: | $2.32 |
| High: | $2.47 |
| Low: | $2.26 |
| Volume: | 41,641 |
| Last Trade Date Time: | 12/04/2023 03:00:00 am |
News | Can-Fite Biopharma Ltd Sponsored ADR (NYSE:CANF)
-
Study will aim to enroll about 20 patients to establish safety and clinical activity Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, tod...
-
2023-11-30 07:08:39 ET More on Can-Fite Biopharma Can-Fite climbs on mid-stage data for liver cancer therapy Can-Fite Biopharma discloses $100M mixed shelf offering - filing Seeking Alpha’s Quant Rating on Can-Fite Biopharma Historical earnings data fo...
Message Board Posts | Can-Fite Biopharma Ltd Sponsored ADR (NYSE:CANF)
| Subject | By | Source | When |
|---|---|---|---|
| Can-Fite to Present at the Emerging Growth Conference | midastouch017 | investorshub | 07/07/2023 12:12:19 PM |
| $CANF Price now last up | kindness | investorshub | 07/05/2023 12:30:23 PM |
| $CANF MomentumIts gaining last up | midastouch017 | investorshub | 07/02/2023 3:49:17 AM |
| $CANF Price gaining | JoEy D BuLL | investorshub | 07/01/2023 12:07:54 AM |
| $CANF Price gaining last trade up | midastouch017 | investorshub | 06/29/2023 2:57:59 PM |
News, Short Squeeze, Breakout and More Instantly...
Can-Fite Biopharma Ltd Sponsored ADR Company Name:
CANF Stock Symbol:
NYSE Market:
Ad
-
Study will aim to enroll about 20 patients to establish safety and clinical activity Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, tod...
-
Advanced liver cancer patient in prior Phase II study remains cancer-free 6.9 years after starting treatment with Namodenoson Can-Fite BioPharma Ltd . (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address ...
-
2023-11-22 09:57:58 ET DENVER, Colo., Nov. 22, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; ESGL Holdings Ltd (NASDAQ: ESGL), SciSparc Ltd (NASDAQ: SPRC), Safety Shot Inc (NASDAQ: SHOT), PaxMedica Inc ...